D
세니젠
188260KOSDAQ38.5 / 100
Reference Date: 2026-10-23
Financial Score7.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Slightly down 3.6% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Senigen is a food safety specialist company established in 2005, leveraging advanced molecular diagnostic technologies like PCR and NGS to provide comprehensive food safety solutions. It has developed key products such as Genelix (high-sensitivity PCR) and GeNext (world's first NGS panel for foodborne pathogen detection), and is expanding into cosmetics and microbiome industries.
Number of Employees
72people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
11.34Industry Average 1.200.0Point
9.5x industry avg (risky)
ROE
-108.63Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
153.31Industry Average 100.000.5Point
1.5x industry avg (risky)
Trend 2023~20252.5 / 10 points
Revenue Growth Rate
0.0 / 3
Avg ▼12.0% (2-year basis)
Operating Profit Growth Rate
2.5 / 3
Avg ▲17.4% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -84.6% (declining, 2yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position6.0Point
52w upper range (65%)
Current 2,020Won52-week high 2,30052-week low 1,484
1-month return2.0Point
1m -3.58% (slight drop)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0